ML-228 is a research compound that activates the hypoxia-inducible factor (HIF) pathway. It features a 1,2,4-triazine core with pyridinyl, biphenylmethylamino, and methyl substituents, and is used as a laboratory tool for studying cellular oxygen sensing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing ML-228?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
2-(1,1,1-trifluoro-2-methylpropan-2-yl)-4H-pyran-4-one
research compound
N-(4-methyl-5-(2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl)thiazol-2-yl)-1H-imidazole-1-carboxamide
research compound
9-bromo-7H-benzo[c]carbazole
research compound
3-Amino-2-bromo-6-methoxypyridine
research compound
6-phenyl-N-[(4-phenylphenyl)methyl]-3-pyridin-2-yl-1,2,4-triazin-5-amine
QNRODODTMXCRKU-UHFFFAOYSA-N
C1=CC=C(C=C1)C2=CC=C(C=C2)CNC3=C(N=NC(=N3)C4=CC=CC=N4)C5=CC=CC=C5
Sourcing ML-228?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.